Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2051
Climb Bio
CLYM
$592M
| $1.49M | ﹤0.01% |
217,300
-103,300
| -32% | -$596K |
2023 Q4
9 quarters
|
|
2052
Eaton Vance Total Return Bond ETF
EVTR
$6.15B
| $1.49M | ﹤0.01% |
+29,300
| New | +$1.51M |
2026 Q1
0 quarters
|
|
2053
Valens Semiconductor
VLN
$176M
| $1.48M | ﹤0.01% |
1,311,700
+170,444
| +15% | +$268K |
2022 Q2
15 quarters
|
|
2054
State Street Materials Select Sector SPDR ETF
XLB
$7.86B
| $1.48M | ﹤0.01% |
29,600
+6,200
| +26% | +$311K |
2025 Q3
2 quarters
|
|
2055
Whitehawk Therapeutics
WHWK
$172M
| $1.48M | ﹤0.01% |
428,622
-12,100
| -3% | -$37.9K |
2019 Q2
27 quarters
|
|
2056
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.05B
| $1.48M | ﹤0.01% |
64,300
-224,600
| -78% | -$5.23M |
2023 Q4
9 quarters
|
|
2057
First Trust Capital Strength ETF
FTCS
$7.54B
| $1.47M | ﹤0.01% |
+15,900
| New | +$1.53M |
2026 Q1
0 quarters
|
|
2058
Peoples Bancorp of North Carolina
PEBK
$237M
| $1.47M | ﹤0.01% |
37,614
+9,407
| +33% | +$354K |
2017 Q2
35 quarters
|
|
2059
ECB Bancorp
ECBK
$179M
| $1.47M | ﹤0.01% |
87,866
-4,534
| -5% | -$78.5K |
2023 Q3
10 quarters
|
|
2060
BTCS Inc
BTCS
$64M
| $1.47M | ﹤0.01% |
1,057,100
+695,555
| +192% | +$1.42M |
2025 Q4
1 quarter
|
|
2061
ALX Oncology
ALXO
$135M
| $1.47M | ﹤0.01% |
732,599
+309,500
| +73% | +$590K |
2025 Q1
4 quarters
|
|
2062
ICU Medical
ICUI
$4.08B
| $1.46M | ﹤0.01% |
11,309
-24,991
| -69% | -$3.59M |
2025 Q1
4 quarters
|
|
2063
Dimensional Emerging Core Equity Market ETF
DFAE
$9.93B
| $1.46M | ﹤0.01% |
+43,100
| New | +$1.51M |
2026 Q1
0 quarters
|
|
2064
Aldeyra Therapeutics
ALDX
$54.3M
| $1.46M | ﹤0.01% |
863,187
+513,187
| +147% | +$2.25M |
2022 Q2
15 quarters
|
|
2065
PRA Group
PRAA
$771M
| $1.46M | ﹤0.01% |
83,332
-41,668
| -33% | -$634K |
2018 Q4
29 quarters
|
|
2066
Dollar Tree
DLTR
$21.8B
| $1.46M | ﹤0.01% |
13,300
-191,403
| -94% | -$23.4M |
2024 Q1
8 quarters
|
|
2067
Petco
WOOF
$690M
| $1.46M | ﹤0.01% |
+523,495
| New | +$1.45M |
2026 Q1
0 quarters
|
|
2068
ProShares UltraShort Ether ETF
ETHD
$65.8M
| $1.45M | ﹤0.01% |
+23,100
| New | +$1.5M |
2026 Q1
0 quarters
|
|
2069
Energy Recovery
ERII
$350M
| $1.45M | ﹤0.01% |
144,265
+41,280
| +40% | +$540K |
2024 Q4
5 quarters
|
|
2070
Encore Capital Group
ECPG
$2.24B
| $1.45M | ﹤0.01% |
20,700
+13,700
| +196% | +$842K |
2020 Q1
24 quarters
|
|
2071
Box
BOX
$5.15B
| $1.45M | ﹤0.01% |
61,308
-330,005
| -84% | -$8.3M |
2016 Q3
38 quarters
|
|
2072
TPG RE Finance Trust
TRTX
$443M
| $1.45M | ﹤0.01% |
185,505
-30,100
| -14% | -$259K |
2018 Q3
30 quarters
|
|
2073
Largo
LGO
$51.6M
| $1.45M | ﹤0.01% |
1,293,300
+1,116,534
| +632% | +$1.52M |
2023 Q4
9 quarters
|
|
2074
Epsilon Energy
EPSN
$182M
| $1.45M | ﹤0.01% |
234,900
-10,500
| -4% | -$53.6K |
2020 Q2
23 quarters
|
|
2075
Global Water Resources
GWRS
$232M
| $1.45M | ﹤0.01% |
190,547
-12,400
| -6% | -$104K |
2017 Q2
35 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.